Philippe Billiald

Statistics

Publications

Citations

1.1K

H-Index

Active since

1983

Affiliations

Muséum national d'Histoire naturelle(Current)

Centre National de la Recherche Scientifique

Université de Tours

Inserm

Hôpital Bichat-Claude-Bernard

Philippe Billiald is an author at Muséum national d'Histoire naturelle specializing in monoclonal antibodies, antibody characterization, and antibody engineering.

ORCID

Publications per year

1983–2022

Publications

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +8

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard et al. · mAbs · 2017 · 92 citations · Full text

Medicine, Hematology, Pharmacology +17

Non-Invasive Molecular Imaging of Fibrosis Using a Collagen-Targeted Peptidomimetic of the Platelet Collagen Receptor Glycoprotein VI

Julien Muzard, Laure Sarda‐Mantel, Stéphane Loyau et al. · PLoS ONE · 2009 · 91 citations · Full text

Medicine, Molecular Biology, Pathology +17

Construction and functional evaluation of a single‐chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion <i>Androctonus australis hector</i>

Christiane Devaux, Emmanuel Moreau, M. Goyffon et al. · European Journal of Biochemistry · 2001 · 64 citations

Pharmacy, Immunology, Molecular Biology +17

A recombinant single‐chain antibody fragment that neutralizes toxin II from the venom of the scorpion <i>Androctonus australis hector</i>

Mohamed Mousli, Christiane Devaux, Hervé Rochat et al. · FEBS Letters · 1999 · 58 citations

Pharmacy, Biotechnology, Molecular Biology +17

1–5 of 32